Sgmo stock premarket
7 Feb 2019 Sangamo Therapeutics Inc. tumbled 48 percent, the most in a decade, after a pair of early-stage studies failed to demonstrate the benefit of two To summarize the above, I have basically told Degiro that I want to want to sell 470 shares of SGMO as soon as the stock price reaches $17 or above. If the stock